Nuvation Bio (NUVB) Earnings Date & Reports

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NUVB is expected to report earnings to fall 34.67% to -11 cents per share on November 11

Nuvation Bio NUVB Stock Earnings Reports

Q3'26

Est.

$-0.12

Q2'26

Missed

by $0.03

Q1'26

Est.

$0.01

Q4'25

Missed

by $0.02

Q3'25

Beat

by $0.01

The last earnings report on August 06 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 6.04M shares outstanding, the current market capitalization sits at 2.43B.

View a ticker or compare two or three

NUVB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days